Live Nasdaq Composite: Tech Stock Strength Buoys Market Sentiment Despite Hawkish Fed

Personal Finance

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

1191 Articles

Drew Wood | Jun 12, 2026 at 11:28 AM EDT

How to Build $12,000 a Month in Dividend Income (And Why Most Investors Underestimate the Cost)

Twelve thousand dollars a month in dividend income sounds simple enough until you start doing the math. Many investors assume…

Drew Wood | Jun 12, 2026 at 8:18 AM EDT

The Dividend Growth Strategy That Turns $50,000 a Year Into $125,000 Without Investing Another Dollar

A $50,000 dividend income stream looks unimpressive next to a $100,000 high-yield payout. Twenty years later, the comparison may look…

David Beren | Jun 12, 2026 at 7:23 AM EDT

Forget JEPI, Goldman’s S&P Income ETF Has Beaten It by 42 Points Since Launch

If you own JPMorgan Equity Premium Income ETF (NYSEARCA:JEPI), you bought it for a reason that still holds. JEPI pays monthly. It…

Alex Sirois | Jun 11, 2026 at 1:08 PM EDT

The Fed Is Poised to Shake Wall Street This Month: Here Is the 1 Dirt-Cheap Stock I’m Loading Up on Anyway

I keep buying Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) because the market keeps handing me a discount on…

Alex Sirois | Jun 11, 2026 at 12:07 PM EDT

Buy, Hold, or Sell: Johnson & Johnson Just Triggered a $1 Billion Oncology Bet. Is It a Buy at $238?

At $238.49, Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) screens as fully valued, with conditions potentially improving on any…

Joel South | Jun 11, 2026 at 10:46 AM EDT

3 No-Brainer Dividend Growth Stocks to Buy in June

With the rate environment stabilizing in mid-2026, income investors are circling back to a familiar playbook: own the businesses that…

Drew Wood | Jun 11, 2026 at 5:57 AM EDT

A $2 Million Dividend Portfolio Cut Its Distribution by $14,400 in One Year and the Holders Did Not Sell

A retired couple with a $2 million dividend-focused portfolio yielding roughly 6%, or $120,000 per year, watched their income stream…

Vandita Jadeja | Jun 10, 2026 at 12:39 PM EDT

I Would Rebuild My Portfolio With Just These 3 Stocks If I Lost Everything Tomorrow

I keep buying NVIDIA, Eli Lilly, and Johnson & Johnson, and if a fire took my brokerage statement to zero…

Drew Wood | Jun 10, 2026 at 11:24 AM EDT

The Portfolio That Gets You a Waterfront Condo in Miami Beach

Ten thousand dollars a month in dividend income works out to $120,000 per year. That is enough to cover the…

Alex Sirois | Jun 10, 2026 at 11:20 AM EDT

Got $1,000? 1 Healthcare King to Buy and Never Sell That Is Safer Than a Treasury Bond

Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) is a rare long-duration compounder because it is the rare equity whose…

Drew Wood | Jun 10, 2026 at 7:04 AM EDT

The Dividend Growth Path That Hauls in a Bigger Paycheck Than Your HR Rep

A $35,000 annual income is roughly comparable to the Social Security benefits many retired couples receive each year. It is…

Vandita Jadeja | Jun 9, 2026 at 3:22 PM EDT

3 Dividend Kings That Pay You While You Sleep

Dividend income lands in your brokerage account every quarter regardless of whether you work, whether the market is roaring, or…

Drew Wood | Jun 9, 2026 at 11:46 AM EDT

The Dividend Strategy That Beats the 4% Rule by $400,000 Over 20 Years on a $1 Million Portfolio

A 65-year-old retiree with $1 million who follows the standard 4% rule withdraws $40,000 in the first year, then increases…

Vandita Jadeja | Jun 9, 2026 at 10:06 AM EDT

Will Johnson & Johnson Stock Hit $300 This Year?

Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) has rallied 13.73% year to date and 55.27% over the past year,…

Jeremy Phillips | Jun 9, 2026 at 8:04 AM EDT

The Cash-Return Pivot: 5 Companies Hiking Dividends Right Now

S&P 500 companies are pivoting hard back to shareholder returns, and the dividend declarations rolling in this spring have already…

1 2 3 4 … 80

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

How to Build $12,000 a Month in Dividend Income (And Why Most Investors Underestimate the Cost)

The Dividend Growth Strategy That Turns $50,000 a Year Into $125,000 Without Investing Another Dollar

Forget JEPI, Goldman’s S&P Income ETF Has Beaten It by 42 Points Since Launch

The Fed Is Poised to Shake Wall Street This Month: Here Is the 1 Dirt-Cheap Stock I’m Loading Up on Anyway

Buy, Hold, or Sell: Johnson & Johnson Just Triggered a $1 Billion Oncology Bet. Is It a Buy at $238?

3 No-Brainer Dividend Growth Stocks to Buy in June

A $2 Million Dividend Portfolio Cut Its Distribution by $14,400 in One Year and the Holders Did Not Sell

I Would Rebuild My Portfolio With Just These 3 Stocks If I Lost Everything Tomorrow

The Portfolio That Gets You a Waterfront Condo in Miami Beach

Got $1,000? 1 Healthcare King to Buy and Never Sell That Is Safer Than a Treasury Bond

The Dividend Growth Path That Hauls in a Bigger Paycheck Than Your HR Rep

3 Dividend Kings That Pay You While You Sleep

The Dividend Strategy That Beats the 4% Rule by $400,000 Over 20 Years on a $1 Million Portfolio

Will Johnson & Johnson Stock Hit $300 This Year?

The Cash-Return Pivot: 5 Companies Hiking Dividends Right Now

Live Nasdaq Composite: Tech Stock Strength Buoys Market Sentiment Despite Hawkish Fed

You Might Already Own SpaceX Shares, Without Even Realizing It

The Magnificent 7 Debt Binge is Sending a Crystal Clear Message to Wall Street. But Are Investors Paying Attention?

Ripple Drops 6%, Bitcoin Falls 5% in Crypto Pullback Defying Stock Rally

You Might Already Own SpaceX Shares, Without Even Realizing It

The $250,000 Nursing Home Bill Was Just the Start. Here's What Happened to His Social Security Next.

Super Micro Is Up 9% Today: Is It Outperforming Other AI Server Stocks Like Dell?

You Might Already Own SpaceX Shares, Without Even Realizing It

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

How to Build $12,000 a Month in Dividend Income (And Why Most Investors Underestimate the Cost)

The Dividend Growth Strategy That Turns $50,000 a Year Into $125,000 Without Investing Another Dollar

Forget JEPI, Goldman’s S&P Income ETF Has Beaten It by 42 Points Since Launch

The Fed Is Poised to Shake Wall Street This Month: Here Is the 1 Dirt-Cheap Stock I’m Loading Up on Anyway

Buy, Hold, or Sell: Johnson & Johnson Just Triggered a $1 Billion Oncology Bet. Is It a Buy at $238?

3 No-Brainer Dividend Growth Stocks to Buy in June

A $2 Million Dividend Portfolio Cut Its Distribution by $14,400 in One Year and the Holders Did Not Sell

I Would Rebuild My Portfolio With Just These 3 Stocks If I Lost Everything Tomorrow

The Portfolio That Gets You a Waterfront Condo in Miami Beach

Got $1,000? 1 Healthcare King to Buy and Never Sell That Is Safer Than a Treasury Bond

The Dividend Growth Path That Hauls in a Bigger Paycheck Than Your HR Rep

3 Dividend Kings That Pay You While You Sleep

The Dividend Strategy That Beats the 4% Rule by $400,000 Over 20 Years on a $1 Million Portfolio

Will Johnson & Johnson Stock Hit $300 This Year?

The Cash-Return Pivot: 5 Companies Hiking Dividends Right Now

Live Nasdaq Composite: Tech Stock Strength Buoys Market Sentiment Despite Hawkish Fed

You Might Already Own SpaceX Shares, Without Even Realizing It

The Magnificent 7 Debt Binge is Sending a Crystal Clear Message to Wall Street. But Are Investors Paying Attention?

Ripple Drops 6%, Bitcoin Falls 5% in Crypto Pullback Defying Stock Rally

Featured Reads

You Might Already Own SpaceX Shares, Without Even Realizing It

The $250,000 Nursing Home Bill Was Just the Start. Here's What Happened to His Social Security Next.